Please login to the form below

Not currently logged in
Email:
Password:

HCC

This page shows the latest HCC news and features for those working in and with pharma, biotech and healthcare.

Tecentriq gains first IO approval in triple negative breast cancer

Tecentriq gains first IO approval in triple negative breast cancer

Roche is also hoping to achieve first-to-market in two other important settings: hepatocellular carcinoma (HCC), where analysts forecast a potential $1bn market opportunity for Tecentriq, and small cell lung

Latest news

More from news
Approximately 4 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Mining for results Mining for results

    The first product to come from Apixio's technology platform is called the HCC Profiler.

  • Pharma Perspectives: The agency selection process (part 2) Pharma Perspectives: The agency selection process (part 2)

    Samuel Hollis is a business unit director at AstraZeneca. In Pharma Perspectives, published in association with the HCC, senior industry and agency figures address key marketing challenges. ... The Health Communications' Council (HCC) is a specialist

  • Pharma Perspectives: The agency selection process (part 1) Pharma Perspectives: The agency selection process (part 1)

    In Pharma Perspectives, published in association with the HCC, senior industry and agency figures address key marketing challenges. ... The Health Communications' Council (HCC) is a specialist division of the European Association of Communications

  • Pharma perspectives: communications creativity (part 2) Pharma perspectives: communications creativity (part 2)

    David Higgins is UK managing director at Sudler &Hennessey Group. He can be contacted via email: David.Higgins@sudler.com  . In the PME/PMLiVE series Pharma Perspectives with the HCC  senior ... If you have a topic you'd like the series to explore

  • Pharma perspectives: communications creativity (part 1) Pharma perspectives: communications creativity (part 1)

    In the PME/PMLiVE series Pharma Perspectives with the HCC senior industry and agency figures give their thoughts on today's key marketing challenges. ... If you have a topic you'd like the series to explore please send it to editor@pmlive.com  . The

More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics